V？is？nen MR, V？is？nen T, Jukkola-Vuorinen A, et al. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors[J]. Prostate, 2010, 70(8):817-824.
[2]
Chuang CM, Monie A, Wu A, et al. Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer[J]. Hum Gene Ther,2009,20(4):303-313.
[3]
Droemann D, Albrecht D, Gerdes J, et al. Human lung cancer cells express functionally active Toll-like receptor 9[J].Respir Res,2005,6(1):1-10.
[4]
Kortylewski M, Kujawski M, Herrmann A, et al. Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy[J]. Cancer Res, 2009, 69(6):2497-2505.
Zeromski J, Mozer-Lisewska I, Kaczmarek M. Significance of Toll-like Receptors Expression in Tumor Growth and Spreading: A Short Review[J]. Cancer Microenviron,2008,1(1):37-42.
[7]
Ren T, Xu L, Jiao S, et al. TLR9 signaling promotes tumor progression of human lung cancer cell in vivo[J]. Pathol Oncol Res,2009,15(4):623-630.
